| Name | Kw-2871 |
|---|
| Description | Ecromeximab (KM 871; KW 2871) is a mouse-derived IgG-κ chimeric antibody targeting ganglioside GD3. Ecromeximab is expressed by YB2/0 rat hybridoma cells[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Ecromeximab. IMGT. |
| No Any Chemical & Physical Properties |